Overview

A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)

Status:
Unknown status

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

This single arm study will assess the safety and efficacy of Endostar combined with chemotherapy (Gemcitabine plus Platinum-based chemotherapy) followed by Endostar maintenance therapy in patients with stage IIIB/IV non-small cell lung cancer (NSCLC).

Phase:

Phase 4

Details

Lead Sponsor:

Simcere Pharmaceutical Co., Ltd

Treatments:

Cisplatin
Endostar protein
Endostatins
Gemcitabine